Related Experiment Video
Updated: Sep 10, 2025
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
791
Systemic mRNA aggregates elicit immunologic reprogramming that unlocks anti-cancer immunity
Hector R Mendez-Gomez1, John A Ligon2, Ashley P Ghiaseddin1
1Lillian S. Wells Department of Neurosurgery, University of Florida, Gainesville, FL, USA.
Human Vaccines & Immunotherapeutics
|August 19, 2025
Summary
Novel mRNA-loaded lipid particle aggregates (RNA-LPAs) reprogram the tumor microenvironment and periphery. This approach generates cancer-specific immunity to combat difficult-to-treat tumors like glioblastoma.
Area of Science:
- Immunology
- Oncology
- Nanotechnology
Background:
- Cancer immunotherapy faces challenges with intratumoral immunosuppression and peripheral tolerance.
- Immunologically 'cold' tumors, such as glioblastoma, are particularly resistant to current treatments.
Purpose of the Study:
- To investigate a novel approach for cancer immunotherapy using mRNA-loaded lipid particle aggregates (RNA-LPAs).
- To assess the ability of RNA-LPAs to overcome immunosuppression and induce cancer-specific immunity.
Main Methods:
- Intravenous administration of mRNA-loaded lipid particle aggregates (RNA-LPAs).
- Reprogramming of the tumor microenvironment and peripheral immune compartments.
Main Results:
- RNA-LPAs successfully reprogrammed both the tumor microenvironment and periphery.
- Simultaneous generation of cancer-specific immunity was achieved.
Conclusions:
- Intravenously administered RNA-LPAs represent a promising strategy for overcoming immunosuppression in cancer.
- This approach holds potential for treating 'cold' tumors by enabling robust, cancer-specific immune responses.
Related Concept Videos
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
02:15Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
01:06Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:23RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K